Advances of Protein Palmitoylation in Tumor Cell Deaths

Xiangyi Lin1, Yuxuan Shi1, Yuxin Zhan1

  • 1Department of Human Cell Biology and Genetics, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.

Cancers
|December 9, 2023
PubMed

Insights

Palmitoylation plays a key role in cancer cell death and growth. New therapies targeting palmitoylation, like Ezurpimtrostat, show promise for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Palmitoylation, a lipid modification, is increasingly recognized for its role in cancer progression and cell death.
  • The DHHC enzyme family and depalmitoylation enzymes like PPT1 are critical regulators of palmitoylation.
  • Advances in detection methods have improved the study of palmitoylation dynamics.

Purpose of the Study:

  • To comprehensively review the role of palmitoylation in various cancer cell death pathways.
  • To explore the connection between palmitoylation, tumorigenesis, and depalmitoylation.
  • To highlight novel therapeutic agents targeting palmitoylation in cancer.

Main Methods:

  • Literature review of existing studies on palmitoylation in oncology.
  • Analysis of the mechanisms involving DHHC enzymes and depalmitoylation.
  • Discussion of emerging therapeutic agents and detection methodologies.

Main Results:

  • Palmitoylation is intricately linked to tumorigenesis and diverse cell death modalities.
  • DHHC enzymes catalyze palmitoylation, while enzymes like PPT1 mediate depalmitoylation.
  • Ezurpimtrostat (GNS561) and dimeric chloroquine (DC661) represent promising therapeutic strategies.

Conclusions:

  • Palmitoylation is a critical regulator of cancer cell fate with significant therapeutic potential.
  • Targeting palmitoylation pathways offers a novel approach for cancer treatment.
  • Further research into palmitoylation dynamics will deepen our understanding of cancer biology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K